January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer occurrence as well as growing drug discoveries for chronic diseases. North America led the market d...
November 01, 2025
Market insights predict the global medical foods for orphan disease industry will increase from USD 8.84 billion in 2024 to USD 14.65 billion by 2034, achieving a CAGR of 5.2%. The market is growing due to rising health awareness, demand for personalized nutrition, and increased focus on rare disease treatments. Advances in biotechnology and suppor...
November 01, 2025
Projections indicate that, the global cell & gene therapy quality control market will increase from USD 2.28 billion in 2024 to USD 22.81 billion by 2034, experiencing a CAGR of 25.74% over the next 10 years.The cell & gene therapy quality control market is growing due to it plays a significant role in ensuring that any cell or gene therapy...
November 01, 2025
Market insights predict, the cell viability assays industry is expected to grow from USD 1.89 billion in 2024 to USD 4.24 billion by 2034, driven by a CAGR of 8.54%. The growing research and development activities and stringent regulatory policies drive the market. The availability of state-of-the-art research and development facilities and favorab...
November 01, 2025
Market insights predict the global non-sterile compounding pharmacy industry will increase from USD 5.97 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 7.34%. The rise in OTC drug demand is driving the non-sterile compounding pharmacy market. North America dominates due to the strong presence of pharmaceutical key players. ...
November 01, 2025
Based on market forecasts, the global advanced therapy medicinal products CDMO market, projected at USD 6.73 billion in 2024, is expected to reach USD 37.27 billion by 2034, growing at a CAGR of 18.82% over the forecast period. The global market is driven by an increase in the pipeline of ATMP candidates in clinical trials, necessary the growth of ...
November 01, 2025
According to market projections, the surgical drapes & gown sector is expected to grow from USD 3.35 billion in 2024 to USD 5.78 billion by 2034, reflecting a CAGR of 5.64%. Generally, the market is driven by a rising geriatric population, the growing case of chronic conditions, and increasing cases of accidents and sports injuries. However, No...
November 01, 2025
Based on market forecasts, the global GCC compounding pharmacy market, projected at USD 16.39 million in 2024, is expected to reach USD 40.26 million by 2034, growing at a CAGR of 9.27% over the forecast period.The growing demand for personalized medicines and technological advancements is the major growth factor of the market. Saudi Arabia led the...
November 01, 2025
According to market projections, the pharmaceutical testing services sector is expected to grow from USD 4.27 billion in 2024 to USD 11.58 billion by 2034, reflecting a CAGR of 10.54%.Due to accelerating heavy investments in R&D and demand for biologics, biosimilars are fueling the global market growth. In this global market, North America do...
November 01, 2025
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceutical contract manufacturing market is growing due to contract manufacturers making significant inves...